Can I taper off duloxetine (Cymbalta) and then start fluvoxamine (Luvox)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can You Taper Off Cymbalta and Start Fluvoxamine?

Yes, you can taper off duloxetine (Cymbalta) and start fluvoxamine, but you must complete a full taper and washout of duloxetine before starting fluvoxamine due to a critical drug interaction that can increase duloxetine levels 6-fold and risk serotonin syndrome.

Critical Drug Interaction

The FDA label for Cymbalta explicitly warns that co-administration of duloxetine with fluvoxamine, a potent CYP1A2 inhibitor, increases duloxetine AUC approximately 6-fold, Cmax 2.5-fold, and half-life 3-fold 1. This massive increase in duloxetine exposure creates serious safety concerns, particularly for serotonin syndrome—a potentially life-threatening condition characterized by mental status changes, neuromuscular hyperactivity, and autonomic instability 2.

Research confirms this interaction: a study found that adding just 25 mg of fluvoxamine to 30 mg duloxetine increased duloxetine plasma levels 3-fold on average, with individual increases ranging from 50-506% 3. This pharmacokinetic interaction occurs because both CYP1A2 and CYP2D6 metabolize duloxetine, and fluvoxamine potently inhibits CYP1A2 (and also affects CYP2C19, CYP2C9, CYP3A4, and CYP2D6) 2, 4.

Safe Switching Protocol

Step 1: Taper Duloxetine Slowly

Duloxetine requires a slow discontinuation taper to minimize withdrawal syndrome 2. Duloxetine is specifically associated with discontinuation symptoms including dizziness, fatigue, nausea, headache, paresthesias, anxiety, and irritability 5.

  • Reduce the dose gradually over several weeks to months depending on your current dose and duration of treatment
  • For patients on duloxetine long-term or at higher risk of withdrawal, use smaller decrements (e.g., 25% reductions every 2-4 weeks initially, then smaller reductions as you approach lower doses)
  • Do not use alternate-day dosing as a tapering strategy—this creates large fluctuations in drug levels and increases withdrawal risk 6
  • Monitor closely for withdrawal symptoms: dizziness, sensory disturbances, anxiety, irritability, nausea, insomnia

Step 2: Complete Washout Period

After the final duloxetine dose, allow adequate time for duloxetine to clear from your system before starting fluvoxamine. Given duloxetine's elimination half-life of approximately 12 hours, waiting at least 3-5 days after the last dose provides reasonable clearance (approximately 5 half-lives).

Step 3: Start Fluvoxamine

Once duloxetine is fully discontinued and washed out:

  • Start fluvoxamine at a low dose (e.g., 25-50 mg daily)
  • Increase gradually as tolerated
  • Monitor for both therapeutic response and adverse effects, particularly in the first 24-48 hours after each dose change 2

Important Caveats

Fluvoxamine itself is associated with discontinuation syndrome 2, so this medication may also require careful tapering if you need to stop it in the future.

Both medications carry risks of serotonin syndrome when combined with other serotonergic drugs 2. Avoid combining with MAOIs, other antidepressants, tramadol, certain opioids, dextromethorphan, and other serotonergic agents.

There is no safe way to cross-taper or overlap these medications due to the severe pharmacokinetic interaction. Conservative switching with complete taper and washout is mandatory 7.

If you experience severe withdrawal symptoms during the duloxetine taper that are intolerable, discuss with your prescriber whether temporarily slowing the taper or using symptomatic management is appropriate—but do not start fluvoxamine until duloxetine is fully discontinued.

Related Questions

What is the safest method to cross‑taper a patient from fluoxetine 40 mg daily to nortriptyline?
How should I cross‑taper from escitalopram 10 mg to fluvoxamine 100 mg?
What is the recommended cross‑taper schedule for switching a patient from citalopram 40 mg to fluoxetine or sertraline?
When switching from sertraline 150 mg daily to fluoxetine, should I perform a cross‑taper?
I am currently taking sertraline 200 mg daily and have excessive morning sleepiness; can I switch to fluoxetine, and if so, how should I taper sertraline, what washout period is needed, and what starting dose of fluoxetine is recommended?
What is the clinical significance of fluctuations in Epstein‑Barr virus (EBV) antibody levels and how do they correlate with disease activity?
Is the use of hypertonic saline nasal irrigation and acetylcysteine nasal spray safe during pregnancy?
Is it safe to take cod liver oil supplements while on clopidogrel (Plavix)?
For a patient with a perioperative risk assessment score of 0.3, what is the recommended surgical plan and pre‑operative preparation?
How should I manage a 68-year-old man with resistant hypertension (blood pressure in the 150 mmHg systolic/90 mmHg diastolic range) who is already taking lisinopril 20 mg daily, hydrochlorothiazide 25 mg daily, carvedilol (Coreg) 12.5 mg twice daily, and amlodipine 5 mg daily?
In a 62-year-old patient taking Armour Thyroid (desiccated thyroid) 60 mg daily who now has a suppressed TSH and a normal total T4, should any changes be made to the thyroid hormone regimen?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.